Study shows potential disparities in early access to Biogen, Eisai's Alzheimer's drug



A new study points to potential racial and economic disparities in patients’ ability to access Biogen and Eisai’s new Alzheimer’s disease drug.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *